Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs HumeCare+

By GLP-1 Scorecard · Updated October 2026

CoreAge Rx is the more direct comparison if you want a prescription service without a tracking-device package. HumeCare+ has a stronger reason to consider it when you will use the connected device and app. We would resolve the written price, renewal choice and refund terms for either before committing: neither headline settles the full purchase.

Compare CoreAge for the medication-and-care purchase

Product pages start at $79 for semaglutide and $129 for tirzepatide, with advertised pricing across doses and no membership fee. Navigation and a separate prepaid campaign have different qualifications. Its FAQ promises no automatic rebills and a full rejection refund, while the policy permits subscriptions and retains an applicable consultation fee. Obtain the selected charge, quantity and refund boundary rather than treating the lowest display as your invoice.

Read the CoreAge Rx review →

Consider HumeCare+ when you want to use the tracking system

The homepage package includes a Hume Pod and app, but labels its $199 monthly headline as a three-month plan; another page describes monthly billing and a first four-week supply. Current terms include consultation and fulfilled prescribed medication within the subscription, with consented additions possible. Its several results-refund advertisements do not have matching claim rules in the current terms. We would choose a confirmed shorter billing arrangement before a larger prepayment.

Read the HumeCare+ review →

This comparison concerns public offers and purchase conditions, not clinical outcomes or interchangeable preparations. Confirm usable supply, testing costs, the treating practice, actual pharmacy and state eligibility. Device readings and muscle-preservation marketing do not establish a treatment benefit; neither provider has been personally tested here.

CoreAge Rx
Site position #1

Higher grade

HumeCare+
Site position #328

Lower grade

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 58.6/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

Visit CoreAge RxVisit HumeCare+

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +38
92
54
Dose & formulationCoreAge Rx +36
88
52
Clinical oversightCoreAge Rx +22
93
71
Labs & monitoringCoreAge Rx +37
90
53
FulfillmentCoreAge Rx +31
95
64
Contract termsCoreAge Rx +6
67
61
CoreAge Rx · top barHumeCare+ · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoreAge RxHumeCare+
WeighScore89.5/10058.6/100
GradeB+C
Site position#1#328
SemaglutideProduct page from $79/mo; navigation $99. Confirm selected quote.GLP-1 page advertises $199 billed monthly and a first four-week supply; homepage labels a three-month plan from $199/month. Confirm the selected total and formulation additions.
TirzepatideFrom $129/mo advertised; confirm selected charge, supply and renewal.Named on the public GLP-1 menu, but no separate current public prescription price confirmed; obtain the selected medication and renewal quote.
CoverageUS only; therapy-specific state restrictions applyHomepage/footer exclude Louisiana and Mississippi; GLP-1 FAQ also excludes Alabama. Confirm current treatment-specific eligibility, especially Alabama.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
CoreAge Rx

Site position #1 · B+

Strengths

  • Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
  • Advertises the same price across doses and no membership fee
  • Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

  • Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
  • FAQ no-rebill and payment-timing statements differ from the subscription and order policy
  • FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
  • Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
  • Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
HumeCare+

Site position #328 · C

Strengths

  • Advertises a Hume Pod and app within the homepage package; other selected plans may differ
  • Current terms describe a single subscription including consultation and prescribed fulfilled medication, with added charges requiring disclosure and consent
  • Publicly identifies MDI Medical Group PC as the clinical network and provides a clinician directory; assignment and current individual licenses still need confirmation
  • Terms allow cancellation before renewal through the account Subscription section or support email

What to consider

  • Homepage three-month pricing and the GLP-1 page’s monthly billing description do not establish one selected initial charge or renewal calendar
  • Ninety-day, 180-day and six-month results-refund advertisements do not have matching claim rules in the current terms; customer-canceled prepaid periods are not prorated
  • Muscle-preservation, side-effect and outcome advantages are merchant claims, not established benefits of the prescribed compound or tracking device
  • No exact prescribing dose, vial quantity, usable supply or patient-lab price is confirmed by the public package
  • The dispensing pharmacy and physical compounder are not named in the reviewed terms or shipping policy
  • Alabama availability differs between the GLP-1 FAQ and site footer; general eligibility does not guarantee every preparation
  • Next-day advertising differs from published clinical-review, pharmacy-processing and carrier estimates; a free included device does not create a separate device cash refund
Alternatives to CoreAge Rx →Alternatives to HumeCare+ →All comparisons →

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard